Using easily accessible peripheral blood mononuclear cell samples, ScaiVision was trained to predict treatment response in patients receiving either a PD-L1 inhibitor or a PD-1 inhibitor.

The cells that are targeted in the blood are known as peripheral blood mononuclear cells (PBMCs). They are “pushed back in time to an earlier time before they became differentiated into heart or ...

The following is a summary of “Monocytic reactive oxygen species-induced T cell apoptosis impairs cellular immune response to ...

Dual blocking SHP2 and FGFR2 can not only promote the targeted tumor-killing effects and overcome FGFR2 inhibitor resistance caused by feedback activation, but also activate T cell-mediated anti-tumor ...

The following is a summary of “Identification of a pancreatic stellate cell gene signature and lncRNA interactions associated ...

Researchers from the Vienna Lung Transplant Program of MedUni Vienna and University Hospital Vienna have published the first prospective, randomized and controlled study on the use of extracorporeal ...

The cells that are targeted in the blood are known as peripheral blood mononuclear cells (PBMCs). They are "pushed back in time to an earlier time before they became differentiated into heart or ...

Plasmacytoid dendritic cells (pDC) primarily function as weak antigen-presenting cells (APC), but have also been shown to ...

Innovative research has provided compelling evidence that perceived stress can directly trigger the relapse of psoriatic skin ...

Novel CD37 antibody-drug conjugate shows promise in targeting the Achilles’ heel of acute myeloid leukemia cells.